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Topic 2 – Heart failure and cardiomyopathy
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Background: The assessment of the left ventricular systolic function is
usually based on the calculation of the ejection fraction by the echocardio-
graphy in the bi-dimensional mode. Some authors suggest that the simple
measurement of the echocardiographic indices (pre-ejection aortic time (PAT)
and aortic ejection time (AET), measured by pulsed Doppler), has a good cor-
relation with left ventricular ejection fraction (LVEF) in dilated cardiomyop-
athy. We propose to study the correlation of these parameters with LV
function in ischemic heart disease and especially its prognostic value.
Methods and results: This is a prospective study that includes 180
consecutive patients admitted for myocardial infarct with an EF <40% in sinus
rhythm and 20 control patients. The assessment of LVEF was performed by
transthoracic echocardiography, LV telediastolic volume, by the biplane Sim-
pson method, the lateral S-wave of the longitudinal LV function in tissue Dop-
pler, the TEI index of the aortic pre ejection time (APT) and aortic ejection
duration (AED) were performed by pulsed Doppler. The value of the APT is
inversely proportional to the LVEF, r=–0.6, P=0.002, and even the ratio APT
/ AED is inversely proportional to the LV EF with a good correlation (r=– 0.7,
p=0.001) and the longitudinal function (S’ wave) (r=–0.65, p=0.002) and pro-
portional for LV volume (for TDV, r=0.65, p=0.01). A ratio value of 0.35 pre-
dicts the LV EF to be <35% with a sensitivity of 90% and a specificity of
81%. The multivariate analysis reveals that this ratio is a predictor of hemo-
dynamic complications (44% vs. 23%, OR=2.1, p=0.01) and hospitalization
for sever heart failure episode at one year (21% vs. 12%, OR=1.9, p=0.001)
regardless of LV function, age and diabetes mellitus.
Conclusion: The aortic pre ejection time (APT), the aortic ejection dura-
tion (AED) and their ratio are simple parameters to measure and they can pre-
dict the impairment of the systolic function and have a short-term prognostic
value in the ischemic heart disease regardless of LV EF.
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Purpose: Animal and clinical data have shown that left bundle branch
block (LBBB) induces mechanical dyssynchrony in the left heart. In heart
failure (HF) patients with low left ventricular (LV) ejection fraction, cardiac
resynchronisation therapy (CRT) is much more efficient when typical LBBB
is present. It has been postulated that lone LBBB could induce a progressive
decline in LV function via dyssynchrony leading to chronic HF with possible
recovery after CRT. However, the clinical evidence to support this hypothesis
is weak. The aim of this work was to study the prevalence and characteristics
of LBBB-induced cardiomyopathy cured by CRT.
Methods: All the patients referred to our center for CRT implantation from
2007 to 2011 (N=375) were investigated for LBBB history. Patients were
included if they presented an original syndrome consisting on:
– history of typical LBBB for ≥5 years,
– no evidence of structural heart disease at the time of LBBB diagnosis,
– progressive development of LV systolic dysfunction and HF symptoms
(NYHA class II-IV),
– presence of major mechanical dyssynchrony by cardiac imaging,
– absence of other etiology for cardiomyopathy,
– hyper-response to CRT as indicated by LVEF>45% after 1 year.
Results: 7 patients (2% of all screened pts) had the described syndrome.
The main patient characteristics and follow-up data are summarized in the fol-
lowing tables. Interestingly, two patients had HF symptoms and LV dysfunc-
tion recurrence after 3 and 6 years of CRT, respectively after withdraw of
CRT due to device removal in one (breast cancer) and battery depletion in the
other. After CRT resume, hyper-response was quickly re-observed in these
two cases.
Conclusion: These original data support the concept of LBBB-induced
cardiomyopathy with possible cure by CRT. The exact prevalence of the syn-
drome, the time needed to develop and predictive factors need to be assessed
in further prospective epidemiological studies.
Table – Main characteristics.
Table – Follow up data. 
060
Prevalence and characteristics of sleep apnoea in patients with stable
heart failure
Hatem Bouraoui, Besma Trimeche, Ayoub Gherairi, Abdallah Mahdhaoui,
Samia Ernez, Gouider Jeridi
Service de cardiologie, Sousse, Tunisie
Background: Heart failure (HF) and sleep apnoea (SA) association has
been recognized but whether it results from confounding factors (hyperten-
sion, ischaemia, obesity) remains unclear.
We aimed to determine the prevalence of SA in HF and to identify poten-
tial risk factors for SA in HF population.
Methods: We prospectively evaluated 70 patients with stable HF on opti-
mized therapy.
Polygraphy was performed. Type and severity of SA were defined
according international criteria. Demographic, anthropometric and clinical
characteristics were collected.
Results: SA was found in 73%, moderate to severe in a significant propor-
tion and predominantly central (63% of patients with SA). 
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Patient characteristics at time of LBBB diagnosis
Male 4
Age (years) 51 (36 to 60)
Chest pain as 1st symptom 2
Rate-dependent LBBB 3
QRS duration (msec) 136 (100 to 160)
Time to HF symptoms (years) 11,5 (5 to 21)
Time to CRT (years) 13,5 (16 to 22)
Pre- and post CRT Pre-implant 1 year
* YHA class I/II/III 0/3/4 5/2/0
* QRS duration (msec) 162 (150 to 180) 124 (110 to 135)
* T-pro BP (pg/ml) 2275±3200 159±11
* LVEF (%) 30 (20 to 39) 53 (45 to 62)
* LVEDD (mm) 63 (50 to 76) 50 (44 to 56)
* p<0,05
